Wednesday, July 19, 2006 / Research Triangle Park, NC — Clinipace, Inc., a software company focused on late-stage clinical research studies and registries today announced its newest software release – Tempo 3.0. Tempo 3.0 is the first web-based software platform that supports the two core functional needs of clinical studies, Clinical Data Capture and Study Management, within a single platform.

TEMPO is a highly flexible and configurable clinical workflow engine that offers comprehensive functionality, including a patented randomization engine embedded within the Clinical Data Capture module, site training, and support for monitoring processes and trial logistics – such as managing investigator payments.

Because Clinipace’s TEMPO is a flexible platform that operates from a single database, pharmaceutical companies, CROs and academic medical centers can decrease their total cost of ownership, reduce risk, accelerate time to study-start, and focus on their research – not on the development and management of technology. TEMPO can be tailored easily and specifically to the needs of a study, and to the management processes of the study sponsor.

Tempo 3.0 also includes improvements targeted specifically at the end-user: an improved graphical user interface, and tools designed to accelerate study implementation that include a new CDISC writer, an administrator tool-kit enabling more efficient and flexible workflow configurations and user account management, as well as the ability to import data from other sources.

“We are extremely pleased to offer our newest Tempo release to our clients,” commented Jeff Williams, CEO of Clinipace. “This latest version stays true to our purpose of streamlining the clinical trial process with a single platform that is the easiest to use and most cost-effective product in the industry, and can also meet the demands of any study regardless of size or scope.”

About Clinipace

Clinipace is a clinical research software company providing a single, integrated data capture and study management platform for post-approval research and registries conducted by biopharmaceutical and medical device companies, Clinical Research Organizations (CROs) and Academic Medical Centers (AMCs). Our platform, called Tempo, is delivered via a web-based, on-demand architecture that streamlines the clinical research process by eliminating the integration headaches associated with multiple platforms, reducing project efforts and costs from startup to conclusion, and empowering project stakeholders to make informed real-time decisions regarding their research.  For more information on Clinipace, please visit: